Skip to content
10-Q

Quarterly Report

XERIS PHARMACEUTICALS INC

0001346302-21-000076

← back to feed
Filed
Aug 5, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 31, 2021 66.5M sh
Capex Q2 2021 · Jun 30, 2021 $647K
Capex restated Q2 2021 · Jun 30, 2020 $172K
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$43.98M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$52.7M
Short Term Investments Q2 2021 · Jun 30, 2021 $52.38M
Short Term Investments Q2 2021 · Dec 31, 2020 $96.19M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $63.6M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $37.6M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $102.47M
Cash And Equivalents Q2 2021 · Dec 31, 2019 $19.52M
Stockholders Equity Q2 2021 · Jun 30, 2021 $19.89M
Stockholders Equity Q2 2021 · Mar 31, 2021 $44.39M
Stockholders Equity Q2 2021 · Dec 31, 2020 $33.76M
Stockholders Equity Q2 2021 · Jun 30, 2020 $24.38M
Stockholders Equity Q2 2021 · Mar 31, 2020 $27.07M
Stockholders Equity Q2 2021 · Dec 31, 2019 $14.44M
Current Liabilities Q2 2021 · Jun 30, 2021 $35.46M
Current Liabilities Q2 2021 · Dec 31, 2020 $28.21M
Total Liabilities Q2 2021 · Jun 30, 2021 $131.61M
Total Liabilities Q2 2021 · Dec 31, 2020 $125.39M
Current Assets Q2 2021 · Jun 30, 2021 $144.59M
Current Assets Q2 2021 · Dec 31, 2020 $152.21M
Total Assets Q2 2021 · Jun 30, 2021 $151.5M
Total Assets Q2 2021 · Dec 31, 2020 $159.15M
Sga Expense Q2 2021 · Jun 30, 2021 $25.93M
Sga Expense Q2 2021 · Jun 30, 2021 $45M
Sga Expense Q2 2021 · Jun 30, 2020 $17.64M
Sga Expense Q2 2021 · Jun 30, 2020 $39.25M
Rd Expense Q2 2021 · Jun 30, 2021 $5.38M
Rd Expense Q2 2021 · Jun 30, 2021 $9.42M
Rd Expense Q2 2021 · Jun 30, 2020 $5.29M
Rd Expense Q2 2021 · Jun 30, 2020 $11.94M
Net Income Q2 2021 · Jun 30, 2021 −$27.52M
Net Income Q2 2021 · Jun 30, 2021 −$45.93M
Net Income Q2 2021 · Mar 31, 2021 −$18.41M
Net Income Q2 2021 · Jun 30, 2020 −$24.1M
Net Income Q2 2021 · Jun 30, 2020 −$53.28M
Net Income Q2 2021 · Mar 31, 2020 −$29.18M
Operating Income Q2 2021 · Jun 30, 2021 −$25.79M
Operating Income Q2 2021 · Jun 30, 2021 −$42.53M
Operating Income Q2 2021 · Jun 30, 2020 −$22.21M
Operating Income Q2 2021 · Jun 30, 2020 −$50.46M
Gross Profit Q2 2021 · Jun 30, 2021 $5.52M
Gross Profit Q2 2021 · Jun 30, 2021 $11.89M
Gross Profit Q2 2021 · Jun 30, 2020 $728K
Gross Profit Q2 2021 · Jun 30, 2020 $726K
Revenue Q2 2021 · Jun 30, 2021 $8.84M
Revenue Q2 2021 · Jun 30, 2021 $16.89M
Revenue Q2 2021 · Jun 30, 2020 $1.99M
Revenue Q2 2021 · Jun 30, 2020 $3.66M